Literature DB >> 26983466

A role for ABCG2 beyond drug transport: Regulation of autophagy.

Rui Ding1, Shengkan Jin1, Kirk Pabon1, Kathleen W Scotto1.   

Abstract

The ABC drug transporters, including ABCG2, are well known for their ability to efflux a wide spectrum of chemotherapeutic agents, thereby conferring a multidrug-resistant phenotype. However, studies over the past several years suggest that the ABC transporters may play additional role(s) in cell survival in the face of stress inducers that are not ABCG2 substrates (i.e., nutrient deprivation, ionizing radiation, rapamycin). The mechanism by which this occurs is largely unknown. In the present study, using several cancer cell lines and their ABCG2-overexpressing sublines, we show that cells overexpressing ABCG2 were more resistant to these stressors. This resistance was associated with an elevated level of autophagy flux, as measured by a higher rate of SQSTM1/p62 degradation and greater accumulation of LC3-II when compared to parental cells. Knockdown of ABCG2 reduced autophagic activity in resistant cells to a level similar to that observed in parental cells, confirming that the enhanced autophagy was ABCG2-dependent. Moreover, using cell viability, apoptosis, and clonogenic assays, we demonstrated that the ABCG2-expressing cells were more resistant to amino acid starvation and radiation-induced cell death. Importantly, knockdown of the critical autophagy factors ATG5 and ATG7 greatly reduced cell survival, verifying that enhanced autophagy was critical for this effect. Taken together, these data indicate that autophagy induced by various stressors is enhanced/accelerated in the presence of ABCG2, resulting in delayed cell death and enhanced cell survival. This defines a new role for this transporter, one with potential clinical significance.

Entities:  

Keywords:  ABC transporters; ABCG2; BCRP; amino acid starvation; autophagy; drug transporters; multidrug resistance; radiation; tumor cell survival

Mesh:

Substances:

Year:  2016        PMID: 26983466      PMCID: PMC4854550          DOI: 10.1080/15548627.2016.1155009

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  52 in total

Review 1.  Deconvoluting the context-dependent role for autophagy in cancer.

Authors:  Eileen White
Journal:  Nat Rev Cancer       Date:  2012-04-26       Impact factor: 60.716

Review 2.  MDR-ABC transporters: biomarkers in rheumatoid arthritis.

Authors:  János Márki-Zay; Katalin Tauberné Jakab; Péter Szerémy; Peter Krajcsi
Journal:  Clin Exp Rheumatol       Date:  2013-05-27       Impact factor: 4.473

3.  ABCG2 expression, function, and promoter methylation in human multiple myeloma.

Authors:  Joel G Turner; Jana L Gump; Chunchun Zhang; James M Cook; Douglas Marchion; Lori Hazlehurst; Pamela Munster; Michael J Schell; William S Dalton; Daniel M Sullivan
Journal:  Blood       Date:  2006-08-17       Impact factor: 22.113

4.  Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.

Authors:  R W Robey; W Y Medina-Pérez; K Nishiyama; T Lahusen; K Miyake; T Litman; A M Senderowicz; D D Ross; S E Bates
Journal:  Clin Cancer Res       Date:  2001-01       Impact factor: 12.531

5.  Xanthines down-regulate the drug transporter ABCG2 and reverse multidrug resistance.

Authors:  Rui Ding; Jia Shi; Kirk Pabon; Kathleen W Scotto
Journal:  Mol Pharmacol       Date:  2011-11-23       Impact factor: 4.436

6.  Characterization of a side population of cancer cells from human gastrointestinal system.

Authors:  Naotsugu Haraguchi; Tohru Utsunomiya; Hiroshi Inoue; Fumiaki Tanaka; Koshi Mimori; Graham F Barnard; Masaki Mori
Journal:  Stem Cells       Date:  2005-10-20       Impact factor: 6.277

7.  Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line.

Authors:  Roberto Mazzanti; Francesca Platini; Consuelo Bottini; Ornella Fantappiè; Michela Solazzo; Luciana Tessitore
Journal:  Biochem Pharmacol       Date:  2009-03-24       Impact factor: 5.858

Review 8.  Regulation mechanisms and signaling pathways of autophagy.

Authors:  Congcong He; Daniel J Klionsky
Journal:  Annu Rev Genet       Date:  2009       Impact factor: 16.830

9.  ABC transporters in cancer: more than just drug efflux pumps.

Authors:  Jamie I Fletcher; Michelle Haber; Michelle J Henderson; Murray D Norris
Journal:  Nat Rev Cancer       Date:  2010-01-15       Impact factor: 60.716

10.  Autophagy as a target for cancer therapy: new developments.

Authors:  Jennifer S Carew; Kevin R Kelly; Steffan T Nawrocki
Journal:  Cancer Manag Res       Date:  2012-10-11       Impact factor: 3.989

View more
  22 in total

Review 1.  Transcription factor-mediated regulation of the BCRP/ABCG2 efflux transporter: a review across tissues and species.

Authors:  Ludwik Gorczyca; Lauren M Aleksunes
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-03-14       Impact factor: 4.481

2.  Differences of basic and induced autophagic activity between K562 and K562/ADM cells.

Authors:  Feifei Wang; Jing Chen; Zhewen Zhang; Juan Yi; Minmin Yuan; Mingyan Wang; Na Zhang; Xuemin Qiu; Hulai Wei; Ling Wang
Journal:  Intractable Rare Dis Res       Date:  2017-11

3.  Intestinal breast cancer resistance protein (BCRP) requires Janus kinase 3 activity for drug efflux and barrier functions in obesity.

Authors:  Jayshree Mishra; Randall Simonsen; Narendra Kumar
Journal:  J Biol Chem       Date:  2019-10-25       Impact factor: 5.157

Review 4.  From Resistance to Sensitivity: Insights and Implications of Biphasic Modulation of Autophagy by Sunitinib.

Authors:  Amal Kamal Abdel-Aziz; Ashraf B Abdel-Naim; Samia Shouman; Saverio Minucci; Mohamed Elgendy
Journal:  Front Pharmacol       Date:  2017-10-10       Impact factor: 5.810

5.  ABCG2-overexpressing H460/MX20 cell xenografts in athymic nude mice maintained original biochemical and cytological characteristics.

Authors:  Wei Zhang; Zhen Chen; Likun Chen; Fang Wang; Furong Li; Xiaokun Wang; Liwu Fu
Journal:  Sci Rep       Date:  2017-01-06       Impact factor: 4.379

6.  Targeting of apoptotic pathways by SMAC or BH3 mimetics distinctly sensitizes paclitaxel-resistant triple negative breast cancer cells.

Authors:  Effrosini G Panayotopoulou; Anna-Katharina Müller; Melanie Börries; Hauke Busch; Guohong Hu; Sima Lev
Journal:  Oncotarget       Date:  2017-07-11

7.  Leishmania LABCG1 and LABCG2 transporters are involved in virulence and oxidative stress: functional linkage with autophagy.

Authors:  José Ignacio Manzano; Ana Perea; David León-Guerrero; Jenny Campos-Salinas; Lucia Piacenza; Santiago Castanys; Francisco Gamarro
Journal:  Parasit Vectors       Date:  2017-05-30       Impact factor: 3.876

Review 8.  ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches.

Authors:  M C Cleophas; L A Joosten; L K Stamp; N Dalbeth; O M Woodward; Tony R Merriman
Journal:  Pharmgenomics Pers Med       Date:  2017-04-20

9.  Dysfunctional ABCG2 gene polymorphisms are associated with serum uric acid levels and all-cause mortality in hemodialysis patients.

Authors:  Akio Nakashima; Kimiyoshi Ichida; Ichiro Ohkido; Keitaro Yokoyama; Hirotaka Matsuo; Yuki Ohashi; Tappei Takada; Akiyoshi Nakayama; Hiroshi Suzuki; Nariyoshi Shinomiya; Mitsuyoshi Urashima; Takashi Yokoo
Journal:  Hum Cell       Date:  2020-03-16       Impact factor: 4.174

10.  The p53-53BP1-Related Survival of A549 and H1299 Human Lung Cancer Cells after Multifractionated Radiotherapy Demonstrated Different Response to Additional Acute X-ray Exposure.

Authors:  Margarita Pustovalova; Lina Alhaddad; Nadezhda Smetanina; Anna Chigasova; Taisia Blokhina; Roman Chuprov-Netochin; Andreyan N Osipov; Sergey Leonov
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.